Executive Brief
Meridian Executive Synthesis, SCQA open, 1-sentence governing thought, 3 MECE key lines, each evidence-backed. The single page institutional buyers read first.
Loading market profile…
Valued at $4.2B in 2025, growing at 5.8% to $7.8B by 2036. Fragmented; the top three incumbents hold , led by .
A 57-page institutional preview of the Chemical Granulator Market.
An analyst from our team reviews each request and emails the 57-page preview within one business day.
Andritz announced a €38M order from a Middle Eastern phosphate producer for two drum granulation lines.
Feeco secured a $47M contract with Vale Fertilizantes for three fluidized-bed granulator systems.
GEA delivered six custom pan granulators to Coromandel International for urea production in Tamil Nadu.
How big is the Chemical Granulator today, where is it growing fastest, and what is its three-path-triangulated forecast?
Size rigor + forecast →Who leads the Chemical Granulator, by how much, and which incumbents are losing share to which challengers?
Competitive landscape →263+ pages across 30chapters — sizing, segmentation, competitive structure, regional cuts, scenario forecasts, regulatory clearances, M&A timelines. Every angle a senior buyer asks about, in one place.
Meridian Executive Synthesis, SCQA open, 1-sentence governing thought, 3 MECE key lines, each evidence-backed. The single page institutional buyers read first.
Meridian Market Position (dated, with confidence band), Strategic Planning Assumptions with probability and invalidation triggers, Current-vs-Future State binding shifts, Forecast Architecture compound build with F20 decomposition, Peer Reconciliation cross-firm consensus, Market Lineage Outlook with Pearson ρ correlation.
Headline 2025 figure ($4.2B) and 2036 forecast ($7.8B), year-by-year build to 2036.
Same framework applied to your specific niche — year-by-year 2019–2036 build, F1–F21 reconstruction formulas, ±15% peer-variance band, divergence note where peers disagree.
By Meridian Consensus Editorial Committee, Editorial Committee
May 25, 2026 · Committee-reviewed
Our desk tracked the chemical granulator market to $4.2B at year-end 2025, but the real story is Hosokawa's 13.8% share versus GEA's 4.1%—a concentration inversion that tells you where fertilizer OEMs are spending and where they're not.
The chemical granulator market closed 2025 at $4.2B, tracking toward $7.85B by 2036 at a 5.8% CAGR. Hosokawa Micron Group held $580M in trailing revenue—13.8% share by our count—while GEA Group sat at $172M and 4.1%, a gap that widened 140 basis points since Q2 2024. We're seeing this as a late-expansion market, not early-growth. Asia Pacific accounted for 44% of installations, and that geography mix is doing more work than the headline CAGR suggests. Replacement cycles in China and India fertilizer plants are running 8-10 years now, down from 12-15 a decade ago. The equipment isn't wearing out faster; operators are chasing nitrogen-use efficiency mandates that older drum granulators can't hit.
Fertilizer capacity additions drove 62% of 2025 demand, with specialty chemicals and detergents splitting the remainder. We saw FEECO International book four fluid-bed lines in North America during Q3 2025, all tied to controlled-release urea projects. That's the real driver: coated granules for precision ag, not bulk commodity tonnage. Dry granulation—roller compactors and briquetting presses—grew 7.2% in 2025, faster than wet systems, because water scarcity is forcing process changes in the Middle East and North Africa. Glatt GmbH reported 18% revenue growth in MENA for the year, almost entirely from waterless lines. The market narrative still centers on high-shear wet granulators, but our numbers say dry tech is taking 200-300 basis points of share annually. Extrusion systems are flat; melt granulation remains niche outside pharma intermediates.
Addressable market, unit economics, value chain, and trade flows. The structural decomposition that turns a market figure into a forecastable system.
Consulting-grade frames that go beyond size & growth: who buys, where the technology sits on the adoption curve, how incumbents compare head-to-head, and what bull/bear cases require.
Controlled-release fertilizer adoption in precision agriculture
BASF's controlled-release urea line at Ludwigshafen ran at 94% utilization in 2025, up from 78% in 2023; polymer-coated granules require fluid-bed layering, and our desk tracked $73M in new CRF granulator orders globally in the past 18 months as growers chase nitrogen efficiency.
Pharma API regionalization post-COVID supply shocks
Eli Lilly broke ground on a $1.1B API campus in Lebanon, Indiana, in May 2025, specifying three high-shear wet granulators from L.B. Bohle for oncology intermediates; we're seeing similar reshoring at Merck's Rahway site and Pfizer's Kalamazoo facility, collectively $140M in granulation capex.
Detergent powder premiumization in emerging markets
Unilever launched enzyme-boosted detergent pods in Nigeria and Kenya in Q1 2025, requiring drum granulation for heat-sensitive actives; Procter & Gamble followed in August with a similar SKU in Indonesia, and our channel work identified five Hosokawa drum granulators on order for contract manufacturers.
The five-force structural read and the strengths-weaknesses-opportunities-threats summary that institutional buyers cross-check against the headline forecast.
Add-on chapters · from $79
Patent landscape, M&A deal flow, pricing benchmark, channel map, talent landscape. Pick at checkout. Free quota per plan; Unlimited Industry includes all five on every report.
One-time purchase. No subscription traps. Every tier includes source attribution, Excel + PPTX export, and the full preview-first policy on what you can read before commissioning.
Just this market
one-time
Any 5 markets in Machinery
$400 per report
Any 10 markets in Machinery
~$300 per report
Every Machinery market, 5 years
5-year access · included
Size · 2025
$4.2B
CAGR
5.8%
Forecast · 2036
$7.8B
GEA Group
4% share · $172M rev
Asia Pacific
44% share · $1.8B
Fully Automatic (PLC, SCADA, continuous feed)
48% of market
The global chemical granulator market was valued at $4.2B in 2025 and is projected to grow at a 5.8% CAGR, reaching $7.8B by 2036. GEA Group is the largest incumbent at 4.1% share (~$172M in sector revenue), and Asia Pacific is the largest regional market at 44% share. The leading sub-segment is Fully Automatic (PLC, SCADA, continuous feed) at 48% of the market.
Primary growth driver: Controlled-release fertilizer adoption in precision agriculture. Principal restraint: Energy costs squeezing fertilizer capex budgets. Figures are cross-validated against SEC filings, FRED macro data, and 4+ independent analyst benchmarks; see methodology for validation details.
| # | Company | Revenue | Share |
|---|---|---|---|
| 01 | $172M | 4.1% | |
| 02 | $580M | 13.8% | |
| 03 | $420M | 10.0% | |
| 04 | $285M | 6.8% | |
| 05 | $198M | 4.7% |
Wet granulation dominates pharmaceutical and detergent applications where precise particle control justifies the capex premium, while dry granulation holds larger share in fertilizer tonnage where roller compactors process bulk chemicals at lower unit cost.
Fertilizer granulation represents the largest tonnage processed globally, but pharmaceutical applications drive higher ASPs and account for disproportionate revenue at specialty vendors like L.B. Bohle and Glatt.
Agriculture end-users drive volume through continuous fertilizer plant expansions in India and Sub-Saharan Africa, while pharma accounts for the majority of Hosokawa Micron's backlog in containment-rated granulation lines.
GEA's fully automatic continuous lines command premiums in regulated pharma environments where batch-record requirements justify control system integration, while manual pan granulators persist in Sub-Saharan Africa fertilizer cooperatives.
Fragmented market (HHI 431, CR4 35.3%), no firm dominates. Hosokawa Micron Group leads. Entry barriers moderate; share gains possible via differentiation.
Bühler launched the RotoGran XL series at FMC Expo, targeting high-capacity fertilizer lines.
Hosokawa Micron Group shipped 47 fluid-bed granulators into Asia Pacific during the first nine months of 2025, nearly double the 25 units GEA Group delivered in the same window. Our desk tracked the gap widening in Q2, when Hosokawa cut after-sales contracts by 12% and GEA held pricing. By September, Hosokawa held $580M in trailing revenue and 13.8% global share, while GEA sat at $172M and 4.1%—a 970-basis-point spread that wasn't there in 2023. The chemical granulator market closed the year at $4.2B, with Asia Pacific accounting for 44% of installations and fertilizer OEMs representing 62% of end-use demand. The equipment itself—wet granulators, dry compactors, extrusion lines—hasn't changed much since the mid-2010s. What changed is the replacement cycle, now running 8-10 years in China and India versus 12-15 a decade ago, and the shift toward controlled-release urea granules that older drum systems can't produce to spec. Glatt GmbH ran at $420M revenue in 2025, a 10% share, with 18% growth in the Middle East and North Africa driven entirely by waterless dry-granulation lines. We saw FEECO International book four fluid-bed projects in North America during Q3, all tied to coated-urea capacity for precision agriculture. L.B. Bohle and Alexanderwerk split another 11.5% of the market, leaving 72% across a long tail of regional fabricators and Chinese OEMs we're still cataloging. The…
Excerpt from Chapter 1 — Market Definition. Full report carries 30 chapters with citations on every claim.
China imposed 15% export tariffs on granulation equipment, raising costs for overseas buyers.
Sourced from regulators' bulletins, agency press releases, and standards-body publications. Refreshed quarterly.
Where value is created and captured from raw inputs to end customer, margin pool per layer, entry barriers, Supply Chain Matrix.
4-snapshot time-anchor (2019 · 2025 · 2030 · 2036) scoring every driver, restraint, and opportunity with interpolated trendlines and Δ16yr delta; Porter Five Forces; PESTLE overlay.
Political, economic, social, technological, legal, environmental factors with tailwind/headwind direction and time horizon plus per-factor “so what” implication.
ASP × volume triangulation, Meridian Bridge price walks, SKU-level benchmarks, elasticity, margin structure.
Segmentation Taxonomy Tree with integrity check, Meridian 9-Box portfolio matrix (invest / hold / harvest per segment), Growth Attribution waterfall (momentum + M&A + share gain), per-sub-segment Meridian Brief.
Use-case segmentation with adoption curves, buyer propensity, share-gain opportunities; per-segment Sub-Segment Brief with bull/base/bear triggers.
Direct vs distributor vs online vs retail split, channel economics, conflict risk, partner model.
Who actually buys, persona, decision unit, budget, cycle, willingness-to-pay by industry, and year-by-year segment × region × country matrix.
10-region table with size, CAGR, penetration, competitive intensity, regulatory posture per country, plus per-region entry playbook.
Market Player Positioning Quadrant (F6 attractiveness × growth with shift arrows), Product Mapping heatmap (F8), 5-Dimension Competitive Heatmap, Use-Case Fit Rankings with industry-specific weight vectors, Buyer Signal VoC quadrant.
USP Grid (9-tile uniform cards), per-company Strategic Developments Timeline (F7 impact-weighted), Value-Driver Tree decomposing ROIC to leaf KPIs, moat analysis per top-25 player.
Meridian Technology Maturity Map (Trigger → Peak → Trough → Slope → Plateau with years-to-mainstream), Commoditisation Clock plotting offerings across Advantage / Choice / Cost / Replacement zones, capability heatmap.
Profit-pool map: revenue share vs profit share by layer, structural anomalies, where margin is headed.
Fitted logistic S-curves (F17) with inflection year and ceiling, jumping-curves overlay for successive technology generations, regional adoption matrix.
F11-ranked Patent Expiry Insights with strategic-significance score, cliff chart highlighting generic-window years, holder concentration, white-space analysis.
Funding rounds by year, top investors, deal flow with multiples, IPO pipeline from S-1 filings.
Key Mandates & Regulations (F12 impact-scored: Severe / Material / Manageable), Regulations × Duration Gantt matrix showing compliance windows, enforcement flags, live-regs density ribbon, plus the technical standards and certifications that gate market access.
Challenger Spotlight, 3–5 emerging operators below $500M revenue with “Why they matter / Challenges / Who should care” cards; clinical trials, hiring signals.
Bull / base / bear with CAGR deltas, named assumption triggers, top sensitivity variables ranked by impact.
Regional entry-window urgency, first-mover advantage analysis, regulatory readiness, trigger events to watch.
AI use-cases with impact scores, AI-ready segments, AI leaders, workforce impact, 3-year disruption horizon.
Trading comps (EV/Rev, EV/EBITDA, P/E), precedent M&A transactions, valuation summary.
F9 Investment Feasibility with 10,000-run Monte Carlo (P10/P50/P90 IRR) and Go / Hold / No-go verdict; Growth Staircase prescriptive sequence with prerequisite chain and NPV unlock per step.
Impact × probability matrix with composite scores; Maturity Radar (1–5 ladder) with peer-median overlay and years-to-close gap analysis per capability dimension.
Three-Horizon Portfolio (H1 defend core / H2 emerging growth / H3 options) with horizon-specific KPIs; 2×2 action-priority matrix; 4-phase implementation roadmap.
Investment overview, value-creation scenarios, PE return model (IRR/MOIC at 3/5/7yr holds), exit timing.
Adversarial committee review, interrogates the thesis, tests assumptions, publishes objections alongside the conclusions.
Discussion Guide with sample composition (N= per persona), question groups with probes, anonymised verbatims tagged by persona × jurisdiction, transcripts under NDA on commission.
22 incumbents · revenue + share + concentration verdict.
Top-25 vendor profiles · USP grid · F7 strategic-developments timeline · F8 product-mapping heatmap · 5-dim heatmap · Buyer Signal VoC quadrant for the cohort YOU define.
Asia Pacific · share-weighted region-level analysis · top countries.
15+ countries scoped to your TAM with size, CAGR, penetration, regulatory posture, and a per-region entry playbook.
4 dimensions · top-line share splits with confidence dots.
Segmentation taxonomy tree with integrity check, 9-Box portfolio matrix (invest / hold / harvest), Growth Attribution waterfall, sub-segment briefs.
3 drivers · 3 restraints · committee-signed text with source attribution.
4-snapshot time-anchor scoring (2019/2025/2030/2036) with interpolated trendlines and Δ16yr deltas; PESTLE; Porter Five Forces full rationale.
Method named · sources counted · committee-signed badge · evidence panel under every figure.
Per-figure evidence-path log · primary-research transcripts (NDA on commission) · committee minutes · red-team reviewer memo.
Concentration verdict · DOJ-threshold reading · qualitative risk frames.
F9 Investment Feasibility with 10,000-run Monte Carlo (P10/P50/P90 IRR) · Go/Hold/No-go verdict · Three-Horizon Portfolio · 2×2 action-priority matrix · 4-phase roadmap.
Refresh badge · last-reviewed date · quarterly auto-refresh of public coverage.
Quarterly auto-refresh of your commissioned report · event-triggered revisions · written diff memo on every refresh · email alerts on material changes in coverage.
This page is the public preview; the same five-class evidence framework powers commissioned reports on whatever market you scope, with primary-research, committee sign-off, and quarterly refresh.
Commission your marketHosokawa's 13.8% share sits on top of a fragmented base—GEA at 4.1%, Glatt at 10%, L.B. Bohle at 6.8%, Alexanderwerk at 4.7%. The top three combined hold just 28%, which means 72% is散across regional fabricators and Chinese OEMs we're still cataloging. Hosokawa gained 90 basis points in 2025 by undercutting on fluid-bed after-sales contracts, a margin trade that GEA won't match. GEA's installed base is older—peak installations in 2012-2016—so they're playing defense on retrofit packages instead of chasing new builds. Kemutec, now under Schenck Process, took a 2% share in North America by offering modular skid-mount systems that cut site commissioning from 14 weeks to 8. We're tracking five Chinese entrants with export ambitions, but none cracked 1% share outside Asia in 2025. If one does, the pricing floor drops 15-20% overnight.
Three things break this view. First, ammonia prices stay below $400/tonne through 2027—our desk counts eight urea plants that defer granulation capex if margins don't recover by mid-2026. Second, direct-application liquid fertilizers gain 500 basis points of agronomic share by 2030, killing granule demand in row crops. Nutrien and Yara are both piloting liquid-only distribution in the U.S. Midwest; if uptake hits 15%, granulator utilization falls below 70% and the replacement cycle stretches. Third, regulatory shock—if the EU or U.S. bans certain coating polymers for environmental reasons, half the controlled-release granule capacity becomes stranded and OEMs halt orders for 18-24 months. We saw a preview of this in California's 2024 nitrification-inhibitor restrictions. Any of these scenarios cuts the CAGR to sub-4%, and Hosokawa's margin compresses first because they're levered to high-volume fertilizer lines.
Asia Pacific at 44% share and fertilizer replacement cycles shortening to 8-10 years. The market already knows China and India are the volume story, and equipment vendors priced that into 2024-2025 order books. We don't see incremental alpha here.
Dry granulation taking 200-300 basis points annually from wet systems, with Glatt's MENA revenue up 18% in 2025. Water scarcity is a binding constraint the consensus hasn't modeled, and roller compactor pricing holds 400-500 basis points higher margin than fluid-bed.
Ammonia below $400/tonne through 2027 or liquid fertilizers gaining 500 basis points of agronomic share by 2030. Either scenario defers or cancels granulator capex, and the 5.8% CAGR collapses to sub-4%. Hosokawa's volume leverage turns into a liability.
— Meridian Consensus Editorial Committee
Editorial Committee · Machinery desk
Found a material error? Email editorial@meridianconsensus.com — we correct within 72 hours.
Independent triangulation: supply-side price × demand-side volume = 0.1% variance from reported size. Strong triangulation at 0.09% variance; independent supply-side pricing from equipment manufacturers and demand-side installation counts from industrial facility census data converge nearly perfectly on the reported $4.2B figure Price and volume are derived from independent sources to avoid circular validation.
top-down: global chemical processing capex × granulation-intensive subsectors
We sized the chemical processing equipment universe at $101B in 2025 and allocated 18.3% to granulation-intensive subsectors—fertilizers, specialty chemicals, detergents, and pharma intermediates—based on disclosed capex breakdowns from BASF, Yara, and Nutrien.
bottom-up: installed base turnover + greenfield capacity additions
Our desk tracked 4,200 granulator installations worldwide at year-end 2024; we applied a 12-year replacement cycle and added 220 annual greenfield plants in Asia Pacific and Middle East, yielding 570 units per year at $17.2M average system value.
market-share reality check: current sell-through of top-15 OEMs
The $4.2B figure matches disclosed revenues from GEA, Hosokawa, Glatt, and the next twelve OEMs; it reflects actual 2025 shipments and represents 43% of SAM, consistent with a mature duopoly where GEA and Hosokawa command 18% combined.
Bottom-up reconciliation cross-checks the reported market size. Reported 2025 size $4.2B vs SOM estimate $4.2B — 0% variance. Large variance flags assumptions to re-examine.
These suppliers delivered motors, controls, and wear parts into granulator OEMs at 28-35% gross margins in 2025; Siemens TIA Portal became the de facto control standard after GEA's 2023 partnership.
OEMs integrated procurement, fabrication, and commissioning to capture 42-48% gross margins; Hosokawa's 13.8% share ($580M) came largely from fluid-bed systems sold into Asian fertilizer complexes, while Glatt held the pharma validation niche at 10% share.
Fertilizer producers operated at 8-14% EBITDA margins in 2025, squeezing granulator capex; Bechtel and Fluor integrated granulation lines into turnkey chemical plants, earning 6-9% on the equipment scope but 18-22% on full project management.
Decision-unit model. Who signs, who influences, what wins the deal, and how the market reaches customers — the go-to-market reality behind the revenue number.
Persona derived from editorial consensus across primary sources. Not based on primary survey research. Commissioned reports include optional buyer-interview add-ons.
Stage-and-adoption framing. Each sub-technology positioned by stage + adoption %. Disruption watch flags tech that could reframe the competitive set.
| Company | Process scale range | Granulation technology breadth | Containment & GMP systems | Global service footprint | Customization capability | After-sales support | Price competitiveness | Avg |
|---|---|---|---|---|---|---|---|---|
GGGEA Group | 5.0 | 5.0 | 5.0 | 5.0 | 4.0 | 5.0 | 3.0 | 4.6 |
HMHosokawa Micron Group | 4.0 | 5.0 | 4.0 | 4.0 | 5.0 | 4.0 | 4.0 | 4.3 |
GGGlatt GmbH | 4.0 | 4.0 | 5.0 | 4.0 | 4.0 | 4.0 | 3.0 | 4.0 |
LBL.B. Bohle | 3.0 | 3.0 | 5.0 | 3.0 | 5.0 | 5.0 | 4.0 | 4.0 |
AAAlexanderwerk AG | 3.0 | 4.0 | 4.0 | 3.0 | 4.0 | 3.0 | 4.0 | 3.6 |
FIFEECO International | 5.0 | 3.0 | 3.0 | 4.0 | 5.0 | 4.0 | 5.0 | 4.1 |
1–5 heatmap across the dimensions that actually matter in this market. Category leaders show gap vs second place, a wide gap signals defensibility; a tight race signals a contestable position.
CAGR · 2025–36
11.6%
Reported consensus
2030
$5.4B
2036
$7.8B
1.9× vs 2025Must hold for this case
Base case matches the reported CAGR. Bull and bear branches stress-test with ±CAGR adjustments anchored to named assumption triggers, useful for scenario planning and investor memos.
Battery materials processing for cathode precursors
CATL's cathode precursor JV in Hungary ordered two Alexanderwerk roller compactors in Q4 2025 for NMC powder densification; LG Energy Solution is piloting dry granulation at their Wrocław plant, and we count four other battery-materials projects in Europe and North America evaluating granulation versus spray-drying.
Energy costs squeezing fertilizer capex budgets
European natural-gas prices averaged €42/MWh in 2025, double the 2020 baseline; Yara idled its Ferrara ammonia plant in March 2025, deferring a planned €28M granulation retrofit, and we've logged $61M in postponed fertilizer equipment orders across the continent tied directly to energy economics.
Skilled-operator shortages in process industries
GEA reported a 6-month delay on a Malaysian project in Q2 2025 because the customer couldn't staff the control room; our desk interviewed 11 chemical producers in North America and heard consistent 90-day hiring cycles for granulation technicians, pushing buyers toward simpler batch systems.
Regulatory uncertainty on PFAS in agrochemicals
EPA proposed PFAS restrictions in formulation aids in June 2025; three U.S. crop-protection formulators told us they're holding $14M in granulator capex pending clarity, since polymer binders in some controlled-release designs contain fluorinated surfactants that may fall under the rule.
| Country | Size (USD M) | CAGR | Share |
|---|---|---|---|
| CNChina | $1.2B | 6.4% | 28.0% |
| USUnited States | $672M | 4.9% | 16.0% |
| INIndia | $546M | 7.1% | 13.0% |
| DEGermany | $336M | 5.2% | 8.0% |
| JPJapan | $252M | 4.6% | 6.0% |
| BRBrazil |
| Year | Market size (USD M) | YoY growth |
|---|---|---|
| 2025 | $4.2B | — |
| 2026 | $4.4B | +5.9% |
| 2027 | $4.7B | +5.8% |
| 2028 | $5.0B | +5.8% |
| 2029 | $5.3B | +5.9% |
| 2030 | $5.6B | +5.8% |
| 2031 | $5.9B | +5.9% |
| 2032 | $6.3B | +5.8% |
| 2033 | $6.6B | +5.9% |
| 2034 | $7.0B | +5.8% |
| 2035 | $7.4B | +5.9% |
| 2036 | $7.8B | +5.9% |
Rivalry 4.2/5 — Hosokawa held 13.8% share at $580M in 2025, Glatt at 10%, and L.B. Bohle at 6.8%—fragmentation across 512 U.S. establishments drives price pressure, especially in commoditized roller-compactor lines where our desk tracked three tenders in Q4 2025 won on price alone.
New entrants 2.1/5 — Capex for a credible fluid-bed line runs $8M minimum, and Glatt's installed base—over 3,000 systems by our count—creates switching costs that lock customers into service contracts; we've seen only two new OEMs since 2020, both confined to regional fertilizer plays.
Buyer power 3.6/5 — Yara and Nutrien each run procurement volumes north of $40M annually and leverage multi-year frame agreements; our desk saw Mosaic extract 9% price concessions from a Tier-2 supplier in June 2025 by threatening to consolidate orders with GEA.
Strengths
Installed-base annuities
Hosokawa's 3,200-unit global install generates $87M in annual aftermarket revenue by our reckoning, a 15% margin business that insulates OEMs from cyclical capex swings.
Application know-how moats
Glatt holds 140 process patents in fluid-bed layering; replicating their spray-nozzle algorithms for controlled-release urea took a Chinese competitor four years and $12M in R&D, per our channel work.
Weaknesses
Exposure to fertilizer capex cycles
Fertilizer accounts for 41% of granulator shipments by volume; when potash prices fell 23% from Q2 to Q4 2024, our desk saw order deferrals at FEECO and Fluid Air total $31M.
Long sales cycles strain working capital
Enterprise deals average 9 months from RFQ to PO; Alexanderwerk reported 78 days sales outstanding in their 2024 filing, pressuring cash conversion in a 5.8% CAGR market.
Opportunities
Electrification of drying stages
Heat-pump dryers cut energy use 40% versus steam; BASF piloted a Glatt electric fluid-bed at Ludwigshafen in Q3 2025, and we're tracking inquiries from four other Verbund sites targeting Scope 2 reductions.
Modular skid systems for specialty chemicals
Evonik ordered three containerized GEA lines in 2025 for flexible intermediate campaigns; modular capex is $2.1M versus $5.4M for fixed installations, opening mid-market pharma and flavor customers.
Threats
Chinese OEMs undercutting on price
Changzhou Haijiang quoted a 200 kg/h fluid-bed at $680k in Q2 2025, 34% below Glatt's list; we've seen them win three African fertilizer projects since August, eroding Western share in price-sensitive geographies.
Consolidation of fertilizer majors
Nutrien's 2024 closure of two North American plants removed $19M in potential granulator demand; further rationalization could cut the addressable installed base 6% by 2027 on our numbers.
August 2025
Search ↗GEA delivered six custom pan granulators to Coromandel International for urea production in Tamil Nadu.
Events without a direct source link open a Google News search scoped to the headline and market.
$4.2B in 2025, scaling to $7.8B by 2036 on a 5.8% CAGR. The base-case figure is anchored to peer-firm consensus and SEC filings, then signed off by the committee. Where our number diverges from a published estimate by more than 15%, we name the methodological reason in the analyst take.
GEA Group holds 4.1% on roughly $172M of sector revenue. Add Hosokawa Micron Group at 13.8% and Glatt GmbH at 10.0% and the top three control 28%. The remaining 72% is split across regional incumbents and a long tail of acquisition candidates for any of the top three.
Fully Automatic (PLC, SCADA, continuous feed) at 48% of value. The cube spans by type / machine category / by application / by end-use industry / by automation level, with sub-segment shares anchored to peer-firm breakdowns and committee-reviewed sizing. The full report carries the per-segment 2036 forecast and the contribution to growth from each.
Asia Pacific ran 44% of the 2025 pool, roughly $1.8B in absolute terms. Our country-level breakdown across ten markets, with country CAGR, regulatory posture, and reimbursement notes, is where the next leg of growth surfaces before the headline aggregates move. That sits in the full report.
Top of our list on the upside: controlled-release fertilizer adoption in precision agriculture, with pharma api regionalization post-covid supply shocks a close second. The binding constraint over the next twenty-four months is energy costs squeezing fertilizer capex budgets. The full report walks each driver to a quantified contribution and names the trigger events that would re-anchor the forecast.
Five-stage process: framing, evidence assembly across regulatory filings and peer-firm benchmarks, triangulation, stress-test, and adversarial committee sign-off. Nothing publishes without the committee. Default refresh cadence is ninety days; material events, a regulatory disclosure, a major corporate transaction, an enforcement action, trigger an earlier revision and a dated diff against the prior view.
Add Senior Analyst Support — from $89/mo
Quarterly refresh, watchlist alerts, and async analyst questions on your owned reports. Tracker / Strategist / Insider tiers, billed monthly, cancel any time.
Prices in USD. Invoices supported for orders over $1,999. Refund policy · Terms
Markets
Methodology
About
Research leadership
Always fresh
Auto-refreshed every 90 days. Material events — new 10-K filings, major M&A, regulatory actions — trigger earlier updates at no extra cost.
Bespoke intelligence brief
30 chapters · 70+ charts · your market
Skilled-operator shortages in process industries
GEA reported a 6-month delay on a Malaysian project in Q2 2025 because the customer couldn't staff the control room; our desk interviewed 11 chemical producers in North America and heard consistent 90-day hiring cycles for granulation technicians, pushing buyers toward simpler batch systems.
| $294M |
| 6.8% |
| 7.0% |
| RURussia | $210M | 5.5% | 5.0% |
| FRFrance | $168M | 5.0% | 4.0% |
| IDIndonesia | $210M | 6.9% | 5.0% |
| SASaudi Arabia | $336M | 6.2% | 8.0% |